Ambulatory services are under one roof
Image content: This image is available to view online.
View image online (https://assets.clevelandclinic.org/transform/fef8e615-d2c6-4bfc-b094-c251ff48d206/650x450-CCC-Hospital_jpg)
650×450-CCC-Hospital
A long-standing dream has been realized. Cleveland Clinic Children’s is now able to provide most pediatric ambulatory services under one roof.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Cleveland Clinic Children’s new home is in the former four-story Taussig Cancer Center on Cleveland Clinic’s main campus. The expansion unites both primary and specialty outpatient care in one convenient, coordinated environment better equipped to manage Cleveland Clinic Children’s 750,000+ patient visits. Children requiring hospitalization or complex care will continue to receive treatment within the M building on Cleveland Clinic’s main campus.
“This is an exciting new chapter in the history of Cleveland Clinic Children’s,” says Rita Pappas, MD, Interim Chair of Cleveland Clinic Children’s. “This new building helps bring visibility to the Cleveland Clinic Children’s brand. More importantly, it allows hundreds of doctors, nurses, therapists and other caregivers to work side-by-side to enhance the care and experience of every child.”
The new, 120,000-square-foot pediatric outpatient center features:
Advertisement
New technologies focused on enhancing patient care and experience include:
Advertisement
Advertisement
Transplant centers vary substantially in how they assess, document and follow patients after allogeneic transplantation
Helping pediatricians and families make safer, more individualized activity decisions
Study finds exome sequencing can uncover additional diagnoses after nondiagnostic panel testing
Early planning can help prevent disruptions in treatment, medication access and support
Survey and focus group findings highlight key concerns among PHM leaders
Surgeons can estimate the location of conduction tissue they cannot see
Pilot program addresses extended wait times for evaluation
Practice implications for donor selection and timing